Challenges in prophylactic therapy with Emicizumab in patients with hemophilia A: Focus on monitoring tests

Publicado en línea: 29 ene 2024

Páginas: 93 - 100

Recibido: 01 nov 2023

Aceptado: 04 dic 2023

DOI: https://doi.org/10.2478/rrlm-2024-0003

Palabras clave

hemophilia A, inhibitors, Emicizumab

© 2024 Melen Brinza et al., published by Sciendo

This work is licensed under the Creative Commons Attribution 4.0 International License.